共 50 条
- [1] Association of pre-treatment ctDNA with disease recurrence and clinical and translational factors in patients with stage IIIB-D/IV melanoma treated with adjuvant immunotherapy (CheckMate 915)ANNALS OF ONCOLOGY, 2022, 33 (07) : S904 - S904Long, G. V.Desai, K.Tang, T.Weber, J. S.Dolfi, S.Ritchings, C.Huang, S-P.Bolisetty, M.Sausen, M.Del Vecchio, M.Larkin, J.Baden, J.Balli, D.Chang, H.Loffredo, J.Zhang, N.Wind-Rotolo, M.Tenney, D.
- [2] Combining total cell-free DNA (cfDNA) and circulating tumor (ctDNA) to enhance the clinical sensitivity of ddPCR assays to detect minimal residual disease (MRD) in stage IIIB/C/IV melanoma patients on adjuvant immunotherapy in CheckMate 238CLINICAL CANCER RESEARCH, 2024, 30 (21)Syeda, Mahrukh M.Wiggins, Jennifer M.Alegun, JosephineAli, SaimMandal, SoutrikTang, TracyDesai, KeyurDolfi, SoniaTenney, Daniel J.Ascierto, Paolo A.Larkin, JamesDel Vecchio, MicheleWeber, Jeffrey S.Polsky, David
- [3] Adjuvant Therapy of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Patients With Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915)JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (03) : 517 - +Weber, Jeffrey S.Schadendorf, DirkDel Vecchio, MicheleLarkin, JamesAtkinson, VictoriaSchenker, MichaelPigozzo, JacopoGogas, HelenDalle, StephaneMeyer, NicolasAscierto, Paolo A.Sandhu, ShahneenEigentler, ThomasGutzmer, RalfHassel, Jessica C.Robert, CarolineCarlino, Matteo S.Di Giacomo, Anna MariaButler, Marcus O.Munoz-Couselo, EvaBrown, Michael P.Rutkowski, PiotrHaydon, AndrewGrob, Jean-JacquesSchachter, JacobQueirolo, Paolade la Cruz-Merino, LuisHaydon, AndrewGrob, Jean-JacquesSchachter, JacobQueirolo, PaolaDe La Cruz-Merino, Luisvan der Westhuizen, AndreMenzies, Alexander M.Re, SandraBas, Tubade Pril, VeerleBraverman, JuliaTenney, Daniel J.Tang, HaoLong, Georgina, V
- [4] Circulating tumour DNA dynamics predict recurrence in stage III melanoma patients receiving neoadjuvant immunotherapyJOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2024, 43 (01)Chan, Wei YenLee, Jenny H.Stewart, AshleighDiefenbach, Russell J.Gonzalez, MariaMenzies, Alexander M.Blank, ChristianScolyer, Richard A.Long, Georgina V.Rizos, Helen
- [5] Adjuvant nivolumab versus ipilimumab in resected stage IIIB-C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trialLANCET ONCOLOGY, 2020, 21 (11): : 1465 - 1477Ascierto, Paolo A.Del Vecchio, MicheleMandala, MarioGogas, HelenArance, Ana M.Dalle, StephaneCowey, C. LanceSchenker, MichaelGrob, Jean-JacquesChiarion-Sileni, VannaMarquez-Rodas, IvanButler, Marcus O.Maio, MicheleMiddleton, Mark R.de la Cruz-Merino, LuisArenberger, PetrAtkinson, VictoriaHill, AndrewFecher, Leslie A.Millward, MichaelKhushalani, Nikhil, IQueirolo, PaolaLobo, Mauricede Pril, VeerleLoffredo, JohnLarkin, JamesWeber, Jeffrey
- [6] Assessment of Prognostic Circulating Tumor Cells in a Phase III Trial of Adjuvant Immunotherapy After Complete Resection of Stage IV MelanomaANNALS OF SURGERY, 2012, 255 (02) : 357 - 362Hoshimoto, SojunFaries, Mark B.Morton, Donald L.Shingai, TatsushiKuo, ChristineWang, He-jingElashoff, RobertMozzillo, NicolaKelley, Mark C.Thompson, John F.Lee, Jeffrey E.Hoon, Dave S. B.
- [7] Adjuvant immunotherapy with tumor infiltrating lymphocytes and interleukin-2 in patients with resected stage III and IV melanomaJOURNAL OF IMMUNOTHERAPY, 2003, 26 (02): : 156 - 162Ridolfi, LRidolfi, RRiccobon, ADe Paola, FPetrini, MStefanelli, MFlamini, ERavaioli, AVerdecchia, GMTrevisan, GAmadori, D
- [8] Association of complementing circulating tumor DNA and circulating tumor cells load on stable and progressive disease in treated patientsJOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)Shafi, GowharRamesh, AarthiManiar, VashistaJoshi, AshishDattatreya, Palanki SatyaDomadia, KshitijLokeshwar, Nilesh MadhukarMahato, PinakiJadhav, Vikas Leelavati BalasahebPatel, Kaushal BabubhaiKalaskar, PritamDongare, ManojGoswami, VikasVasudevan, AravindanAland, GourishankarJayant, SreejaBharde, AtulDeshmane, VinayBasade, Maheboob M.Khandare, Jayant
- [9] Use of circulating tumor DNA analysis to predict recurrence and need for adjuvant chemotherapy in stage I-IV colorectal cancerJOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)Li, Li-RenFan, WenhuaXia, ZhiyuanChen, RongrongLin, DaguiLi, FangZheng, YangLuo, JiongyongXiong, YuanyuanYu, PengliGao, WeiGong, YuhuaZhang, SenZhang, Feiran
- [10] Adjuvant therapy with nivolumab (NIVO) combined with ipilimumab (IPI) vs NIVO alone in patients (pts) with resected stage IIIB-D/IV melanoma (CheckMate 915).CANCER RESEARCH, 2021, 81 (13)Long, Georgina V.Schadendorf, DirkDel Vecchio, MicheleLarkin, JamesAtkinson, VictoriaSchenker, MichaelPigozzo, JacopoGogas, Helen J.Dalle, StephaneMeyer, NicolasAscierto, Paolo A.Sandhu, ShahneenEigentler, ThomasGutzmer, RalfHassel, Jessica C.Robert, CarolineCarlino, MatteoDi Giacomo, Anna MariaButler, Marcus O.Munoz-Couselo, EvaBrown, Michael P.Rutkowski, PiotrHaydon, AndrewGrob, Jean-JacquesSchachter, JacobQueirolo, PaolaMenzies, AlexanderRe, SandraBas, Tuba O.de Pril, VeerleTenney, DanielTang, HaoWeber, Jeffrey S.